{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:39:58Z","timestamp":1785879598221,"version":"3.56.0"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009856","name":"L. K. Whittier Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0231765","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T18:41:41Z","timestamp":1587062501000},"page":"e0231765","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Urine dicarboxylic acids change in pre-symptomatic Alzheimer\u2019s disease and reflect loss of energy capacity and hippocampal volume"],"prefix":"10.1371","volume":"15","author":[{"given":"K. J.","family":"Castor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Shenoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. P.","family":"Edminster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. S.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Chui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Pogoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. N.","family":"Fonteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7923-8032","authenticated-orcid":true,"given":"M. G.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,4,16]]},"reference":[{"issue":"4","key":"pone.0231765.ref001","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jalz.2016.03.001","article-title":"2016 Alzheimer's disease facts and figures","volume":"12","author":"A. Alzheimer's","year":"2016","journal-title":"Alzheimer's & dementia: the journal of the Alzheimer's Association"},{"issue":"1","key":"pone.0231765.ref002","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1749-6632.2000.tb05554.x","article-title":"Toward a Comprehensive Theory for Alzheimer's Disease. Hypothesis: Alzheimer's Disease Is Caused by the Cerebral Accumulation and Cytotoxicity of Amyloid \u03b2-Protein.","volume":"924","author":"DJ Selkoe","year":"2006","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"6","key":"pone.0231765.ref003","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/WCO.0b013e32835a30f4","article-title":"Origins of Alzheimer's disease: reconciling cerebrospinal fluid biomarker and neuropathology data regarding the temporal sequence of amyloid-beta and tau involvement","volume":"25","author":"ES Musiek","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"pone.0231765.ref004","unstructured":"2016 Alzheimer's Disease Facts and Figures [website]. Alzheimer's Association; 2016 [cited 2016 September 13]. Available from: www.alz.org\/facts\/overview.asp."},{"issue":"6","key":"pone.0231765.ref005","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.mayocp.2017.02.011","article-title":"Alzheimer Disease: Scientific Breakthroughs and Translational Challenges","volume":"92","author":"RJ Caselli","year":"2017","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"pone.0231765.ref006","first-page":"56","article-title":"CAP\u2014advancing the evaluation of preclinical Alzheimer disease treatments","volume":"12","author":"EM Reiman","year":"2016","journal-title":"Nature reviews"},{"issue":"1","key":"pone.0231765.ref007","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jalz.2016.07.005","article-title":"The DIAN-TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model","volume":"13","author":"RJ Bateman","year":"2017","journal-title":"Alzheimer's & dementia: the journal of the Alzheimer's Association"},{"issue":"4","key":"pone.0231765.ref008","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1212\/01.WNL.0000046581.81650.D0","article-title":"CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study","volume":"60","author":"D Strozyk","year":"2003","journal-title":"Neurology"},{"issue":"2","key":"pone.0231765.ref009","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"CR Jack","year":"2013","journal-title":"Lancet Neurol"},{"issue":"3","key":"pone.0231765.ref010","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archneurol.2008.596","article-title":"Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain","volume":"66","author":"T Tapiola","year":"2009","journal-title":"Arch Neurol"},{"key":"pone.0231765.ref011","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neuroimage.2017.07.050","article-title":"AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure","volume":"161","author":"S Mishra","year":"2017","journal-title":"Neuroimage"},{"issue":"3","key":"pone.0231765.ref012","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bbadis.2011.11.005","article-title":"PET amyloid-beta imaging in preclinical Alzheimer's disease","volume":"1822","author":"AG Vlassenko","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"pone.0231765.ref013","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/ana.24719","article-title":"Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease","volume":"80","author":"AG Vlassenko","year":"2016","journal-title":"Ann Neurol"},{"issue":"9","key":"pone.0231765.ref014","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/jamaneurol.2015.1285","article-title":"Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age","volume":"72","author":"CL Sutphen","year":"2015","journal-title":"JAMA neurology"},{"issue":"1","key":"pone.0231765.ref015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13195-015-0142-1","article-title":"Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort","volume":"7","author":"MI Kester","year":"2015","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"pone.0231765.ref016","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/jamaneurol.2016.0086","article-title":"Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease","volume":"73","author":"R Tarawneh","year":"2016","journal-title":"JAMA neurology"},{"issue":"8","key":"pone.0231765.ref017","doi-asserted-by":"crossref","first-page":"e0182098","DOI":"10.1371\/journal.pone.0182098","article-title":"A multivariate predictive modeling approach reveals a novel CSF peptide signature for both Alzheimer's Disease state classification and for predicting future disease progression","volume":"12","author":"DA Llano","year":"2017","journal-title":"PloS one"},{"issue":"Suppl 1","key":"pone.0231765.ref018","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40120-017-0073-9","article-title":"A Review of Fluid Biomarkers for Alzheimer's Disease: Moving from CSF to Blood","volume":"6","author":"K. Blennow","year":"2017","journal-title":"Neurol Ther"},{"issue":"5","key":"pone.0231765.ref019","doi-asserted-by":"crossref","first-page":"e63644","DOI":"10.1371\/journal.pone.0063644","article-title":"Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics","volume":"8","author":"E Trushina","year":"2013","journal-title":"PloS one"},{"issue":"10","key":"pone.0231765.ref020","doi-asserted-by":"crossref","first-page":"e0139233","DOI":"10.1371\/journal.pone.0139233","article-title":"Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers","volume":"10","author":"G Lugli","year":"2015","journal-title":"PloS one"},{"issue":"2","key":"pone.0231765.ref021","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3233\/JAD-180412","article-title":"Early Candidate Urine Biomarkers for Detecting Alzheimer's Disease Before Amyloid-beta Plaque Deposition in an APP (swe)\/PSEN1dE9 Transgenic Mouse Model","volume":"66","author":"F Zhang","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"pone.0231765.ref022","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3109\/1354750X.2014.994036","article-title":"Combining serum and urine biomarkers in the early diagnosis of mild cognitive impairment that evolves into Alzheimer's disease in patients with the apolipoprotein E 4 genotype","volume":"20","author":"C Wang","year":"2015","journal-title":"Biomarkers"},{"issue":"5","key":"pone.0231765.ref023","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jamda.2010.03.004","article-title":"Urine neural thread protein measurements in Alzheimer disease","volume":"12","author":"YC Youn","year":"2011","journal-title":"J Am Med Dir Assoc"},{"key":"pone.0231765.ref024","article-title":"Ultrasensitive Detection of Plasma Amyloid-beta as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease","author":"P Chatterjee","year":"2019","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"pone.0231765.ref025","first-page":"419","article-title":"SILK studies\u2014capturing the turnover of proteins linked to neurodegenerative diseases","volume":"15","author":"RW Paterson","year":"2019","journal-title":"Nature reviews"},{"key":"pone.0231765.ref026","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neurobiolaging.2017.01.021","article-title":"The biomarker-based diagnosis of Alzheimer's disease. 2-lessons from oncology","volume":"52","author":"M Boccardi","year":"2017","journal-title":"Neurobiol Aging"},{"issue":"2","key":"pone.0231765.ref027","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0005-2760(93)90124-R","article-title":"Saturated dicarboxylic acids as products of unsaturated fatty acid oxidation","volume":"1168","author":"S Passi","year":"1993","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"pone.0231765.ref028","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0021-9150(99)00263-4","article-title":"Dicarboxylic acids as markers of fatty acid peroxidation in diabetes","volume":"148","author":"M Inouye","year":"2000","journal-title":"Atherosclerosis"},{"issue":"2","key":"pone.0231765.ref029","doi-asserted-by":"crossref","first-page":"C228","DOI":"10.1152\/ajpcell.00148.2017","article-title":"The dawn of succinylation: a posttranslational modification","volume":"314","author":"M Alleyn","year":"2018","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"pone.0231765.ref030","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.celrep.2013.07.024","article-title":"Lysine succinylation is a frequently occurring modification in prokaryotes and eukaryotes and extensively overlaps with acetylation","volume":"4","author":"BT Weinert","year":"2013","journal-title":"Cell Rep"},{"issue":"12","key":"pone.0231765.ref031","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.ebiom.2015.11.002","article-title":"White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease","volume":"2","author":"LP Klosinski","year":"2015","journal-title":"EBioMedicine"},{"key":"pone.0231765.ref032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2015.05.001","article-title":"Impaired mitochondrial energy metabolism in Alzheimer's disease: Impact on pathogenesis via disturbed epigenetic regulation of chromatin landscape","volume":"131","author":"A Salminen","year":"2015","journal-title":"Prog Neurobiol"},{"key":"pone.0231765.ref033","article-title":"Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition","author":"JR Filon","year":"2016","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1\u20132","key":"pone.0231765.ref034","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1155\/2006\/202938","article-title":"Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods","volume":"22","author":"AN Fonteh","year":"2006","journal-title":"Disease Markers"},{"issue":"16","key":"pone.0231765.ref035","doi-asserted-by":"crossref","first-page":"e1890","DOI":"10.1212\/WNL.0000000000007279","article-title":"A prospective study of serum metabolites and risk of ischemic stroke","volume":"92","author":"D Sun","year":"2019","journal-title":"Neurology"},{"issue":"3","key":"pone.0231765.ref036","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/WAD.0b013e318142774e","article-title":"The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set","volume":"21","author":"DL Beekly","year":"2007","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"11","key":"pone.0231765.ref037","doi-asserted-by":"crossref","first-page":"e79378","DOI":"10.1371\/journal.pone.0079378","article-title":"Executive function changes before memory in preclinical Alzheimer's pathology: a prospective, cross-sectional, case control study","volume":"8","author":"MG Harrington","year":"2013","journal-title":"PloS one"},{"key":"pone.0231765.ref038","article-title":"Boston Naming Test predicts deterioration of cerebrospinal fluid biomarkers in pre-symptomatic Alzheimer\u2019s disease","author":"C Wilder","year":"2018","journal-title":"FASEB J"},{"issue":"6","key":"pone.0231765.ref039","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0731-7085(99)00235-6","article-title":"Quantitative analysis of urinary acylglycines for the diagnosis of \u03b2-oxidation defects using GC-NCI-MS","volume":"21","author":"CG Costa","year":"2000","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"issue":"Suppl 1","key":"pone.0231765.ref040","doi-asserted-by":"crossref","first-page":"s4","DOI":"10.1185\/0300799039117005","article-title":"Epidemiology and economic impact of migraine","volume":"17","author":"RB Lipton","year":"2001","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"pone.0231765.ref041","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7326\/0003-4819-139-4-200308190-00006","article-title":"Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis","volume":"139","author":"TH Jafar","year":"2003","journal-title":"Ann Intern Med"},{"issue":"2","key":"pone.0231765.ref042","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1289\/ehp.7337","article-title":"Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements","volume":"113","author":"DB Barr","year":"2005","journal-title":"Environ Health Perspect"},{"issue":"2","key":"pone.0231765.ref043","first-page":"171","article-title":"Comparison of uncertainties related to standardization of urine samples with volume and creatinine concentration","volume":"48","author":"AH Garde","year":"2004","journal-title":"Ann Occup Hyg"},{"issue":"2","key":"pone.0231765.ref044","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1212\/WNL.0000000000003482","article-title":"Dementia risk in renal dysfunction: A systematic review and meta-analysis of prospective studies","volume":"88","author":"K Deckers","year":"2017","journal-title":"Neurology"},{"issue":"6","key":"pone.0231765.ref045","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/jgs.14750","article-title":"Albuminuria in Association with Cognitive Function and Dementia: A Systematic Review and Meta-Analysis","volume":"65","author":"MK Georgakis","year":"2017","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"pone.0231765.ref046","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1053\/j.ajkd.2016.04.017","article-title":"Estimated GFR, Albuminuria, and Cognitive Performance: The Maastricht Study","volume":"69","author":"RJ Martens","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"1\u20132","key":"pone.0231765.ref047","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/ars.2005.7.269","article-title":"F2-isoprostanes in Alzheimer and other neurodegenerative diseases","volume":"7","author":"TJ Montine","year":"2005","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"pone.0231765.ref048","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0005-2760(93)90124-R","article-title":"Saturated dicarboxylic acids as products of unsaturated fatty acid oxidation","volume":"1168","author":"S Passi","year":"1993","journal-title":"Biochimica et Biophysica Acta (BBA)\u2014Lipids and Lipid Metabolism"},{"issue":"2","key":"pone.0231765.ref049","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0005-2760(81)90056-4","article-title":"Urinary excretion of C4\u2014C10-dicarboxylic acids and antiketogenic properties of adipic acid in ketogenic-stimulated rats due to diabetes, long-chain and short-chain monocarboxylic acids","volume":"664","author":"PB Mortensen","year":"1981","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"pone.0231765.ref050","first-page":"1580","article-title":"Ethylmalonic-adipic aciduria. In vivo and in vitro studies indicating deficiency of activities of multiple acyl-CoA dehydrogenases","volume":"64","author":"S Mantagos","year":"1979","journal-title":"J Clin Invest"},{"key":"pone.0231765.ref051","first-page":"15","article-title":"C6-C10-dicarboxylic aciduria: biochemical considerations in relation to diagnosis of beta-oxidation defects","volume":"161","author":"N Gregersen","year":"1982","journal-title":"Scand J Clin Lab Invest Suppl"},{"issue":"12","key":"pone.0231765.ref052","doi-asserted-by":"crossref","first-page":"e53354","DOI":"10.1371\/journal.pone.0053354","article-title":"Standardization of diagnostic biomarker concentrations in urine: the hematuria caveat","volume":"7","author":"CN Reid","year":"2012","journal-title":"PloS one"},{"issue":"8","key":"pone.0231765.ref053","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1096\/fj.201700065R","article-title":"Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids","volume":"31","author":"M Fiala","year":"2017","journal-title":"FASEB J"},{"issue":"Suppl","key":"pone.0231765.ref054","doi-asserted-by":"crossref","first-page":"S400","DOI":"10.1194\/jlr.R800068-JLR200","article-title":"Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer's disease","volume":"50","author":"NG Bazan","year":"2009","journal-title":"J Lipid Res"},{"issue":"6","key":"pone.0231765.ref055","doi-asserted-by":"crossref","first-page":"e100519","DOI":"10.1371\/journal.pone.0100519","article-title":"Human cerebrospinal fluid fatty acid levels differ between supernatant fluid and brain-derived nanoparticle fractions, and are altered in Alzheimer's disease","volume":"9","author":"AN Fonteh","year":"2014","journal-title":"PloS one"},{"key":"pone.0231765.ref056","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-1-4939-3524-6_2","article-title":"Quantitative Analysis of the Sirt5-Regulated Lysine Succinylation Proteome in Mammalian Cells","volume":"1410","author":"Y. Chen","year":"2016","journal-title":"Methods Mol Biol"},{"issue":"2","key":"pone.0231765.ref057","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s12017-014-8288-8","article-title":"Distinct patterns of sirtuin expression during progression of Alzheimer's disease","volume":"16","author":"MI Lutz","year":"2014","journal-title":"Neuromolecular Med"},{"key":"pone.0231765.ref058","doi-asserted-by":"crossref","DOI":"10.1007\/s11064-019-02780-x","article-title":"Succinylation Links Metabolism to Protein Functions","author":"Y Yang","year":"2019","journal-title":"Neurochem Res"},{"issue":"1","key":"pone.0231765.ref059","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/jnc.13096","article-title":"Alpha-ketoglutarate dehydrogenase complex-dependent succinylation of proteins in neurons and neuronal cell lines","volume":"134","author":"GE Gibson","year":"2015","journal-title":"J Neurochem"},{"key":"pone.0231765.ref060","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mehy.2018.09.018","article-title":"Succinylation as a novel mode of energy metabolism regulation during atrial fibrillation","volume":"121","author":"F Bai","year":"2018","journal-title":"Med Hypotheses"},{"issue":"2","key":"pone.0231765.ref061","doi-asserted-by":"crossref","first-page":"H347","DOI":"10.1152\/ajpheart.00900.2015","article-title":"Acetylation and succinylation contribute to maturational alterations in energy metabolism in the newborn heart","volume":"311","author":"A Fukushima","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"pone.0231765.ref062","doi-asserted-by":"crossref","first-page":"8529404","DOI":"10.1155\/2017\/8529404","article-title":"Biochemical Analysis of Histone Succinylation","volume":"2017","author":"A Yokoyama","year":"2017","journal-title":"Biochem Res Int"},{"key":"pone.0231765.ref063","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.nbd.2014.11.013","article-title":"Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology","volume":"81","author":"E Isopi","year":"2015","journal-title":"Neurobiol Dis"},{"issue":"2","key":"pone.0231765.ref064","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/jnr.10648","article-title":"Pyruvate protection against beta-amyloid-induced neuronal death: role of mitochondrial redox state","volume":"73","author":"G Alvarez","year":"2003","journal-title":"J Neurosci Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0231765","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T18:42:29Z","timestamp":1587062549000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0231765"}},"subtitle":[],"editor":[{"given":"Stephen D.","family":"Ginsberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,4,16]]},"references-count":64,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0231765","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,16]]}}}